Published in Arch Intern Med on October 28, 2002
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res (2008) 1.82
Symptomatic venous thromboembolism and mortality in orthopaedic surgery - an observational study of 45 968 consecutive procedures. BMC Musculoskelet Disord (2013) 0.95
Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study. Int Orthop (2012) 0.88
Prevention of venous thromboembolism in patients undergoing bariatric surgery. Vasc Health Risk Manag (2015) 0.85
Thromboprophylaxis and orthopaedic surgery: options and current guidelines. Malays J Med Sci (2014) 0.78
Clinical use of parnaparin in major and minor orthopedic surgery: a review. Vasc Health Risk Manag (2008) 0.75
Effect of heparin on prevention of flap loss in microsurgical free flap transfer: a meta-analysis. PLoS One (2014) 0.75
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med (2008) 6.32
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet (2007) 5.41
Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb (2003) 4.44
Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med (2013) 4.43
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet (2010) 3.36
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr (2007) 2.89
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013. Arch Cardiovasc Dis (2013) 2.71
Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke (2009) 2.30
Association of Takayasu's arteritis and Crohn's disease. Results of a study on 44 Takayasu patients and review of the literature. Ann Med Interne (Paris) (2003) 2.25
Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study. Radiology (2008) 2.25
Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model. Anesthesiology (2012) 2.25
Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial. AIDS (2002) 2.03
Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal. AIDS (2003) 1.94
Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock. Intensive Care Med (2007) 1.67
Assessing the severity of migraine: development of the MIGSEV scale. Headache (2003) 1.65
Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stress. Crit Care Med (2009) 1.61
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study. Thromb Res (2012) 1.58
The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study. Anesth Analg (2007) 1.55
Community-acquired infectious diarrhoea in children under 5 years of age in Dakar, Senegal. Paediatr Int Child Health (2013) 1.49
Postoperative myocardial damages after hip fracture repair are frequent and associated with a poor cardiac outcome: a three-hospital study. Age Ageing (2009) 1.48
Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography. Thromb Res (2010) 1.45
Multiple myeloma with unusual inclusions. Br J Haematol (2008) 1.39
P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study. Circulation (2003) 1.31
Clinically relevant interpretation of genotype for resistance to abacavir. AIDS (2003) 1.27
Virological responses to atazanavir-ritonavir-based regimens: resistance-substitutions score and pharmacokinetic parameters (Reyaphar study). Antivir Ther (2006) 1.19
Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays. J Acquir Immune Defic Syndr (2011) 1.17
Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions. Eur J Hum Genet (2008) 1.14
Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). Eur J Cardiothorac Surg (2011) 1.09
Identification of hepatitis B virus subgenotype A3 in rural Gabon. J Med Virol (2006) 1.08
CT venography and compression sonography are diagnostically equivalent: data from PIOPED II. AJR Am J Roentgenol (2007) 1.05
Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre study. Thromb Res (2012) 1.05
Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Mod Pathol (2008) 1.05
Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa. AIDS (2005) 1.02
Increased carotid wall stress in vascular Ehlers-Danlos syndrome. Circulation (2004) 1.00
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool. Haematologica (2003) 1.00
Laboratory identification of cryoglobulinemia from automated blood cell counts, fresh blood samples, and blood films. Am J Clin Pathol (2002) 0.99
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094). Vaccine (2005) 0.99
Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty. Thromb Res (2012) 0.98
In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits. Circulation (2002) 0.98
Thromboprophylaxis in patients older than 75 years or with moderate renal impairment undergoing knee or hip replacement surgery [corrected]. Int Orthop (2011) 0.98
Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood (2006) 0.97
Low immune response to hepatitis B vaccine among children in Dakar, Senegal. PLoS One (2012) 0.95
Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastim. Crit Rev Oncol Hematol (2010) 0.94
An electronic tool for venous thromboembolism prevention in medical and surgical patients. Haematologica (2006) 0.94
The ''critical thrombosis period'' in major orthopedic surgery: when to start and when to stop prophylaxis. Clin Appl Thromb Hemost (2009) 0.94
Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spots. J Clin Microbiol (2013) 0.92
Evaluation of an in-house ELISA using the intermediate species Leptospira fainei for diagnosis of leptospirosis. J Med Microbiol (2013) 0.92
Platelet satellitism and lympho-agglutination as presenting finding in marginal zone B-cell lymphoma. Eur J Haematol (2009) 0.91
Good clinical practice in developing countries: applying recommendations. Therapie (2008) 0.91
Adenosine inhibits tissue factor expression by LPS-stimulated human monocytes: involvement of the A3 adenosine receptor. Thromb Haemost (2002) 0.90
Perioperative platelet transfusion: recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS) 2003. Can J Anaesth (2005) 0.90
Oral bioavailability of a low molecular weight heparin using a polymeric delivery system. J Control Release (2006) 0.90
Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anaesth (2005) 0.90
Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load. PLoS One (2011) 0.89
Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007). Antivir Ther (2012) 0.88
Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. Br J Haematol (2007) 0.88
Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection. J Clin Virol (2013) 0.88
Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants. Thromb Haemost (2003) 0.87
Aprotinin versus placebo in major orthopedic surgery: a randomized, double-blinded, dose-ranging study. Anesth Analg (2002) 0.87
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. J Thromb Thrombolysis (2011) 0.86
Update on the MONITOR-GCSF study of biosimilar filgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia in cancer patients: Protocol amendments. Crit Rev Oncol Hematol (2011) 0.86
Frequency of thrombocytopenia and large platelets correlates neither with conotruncal cardiac anomalies nor immunological features in the chromosome 22q11.2 deletion syndrome. Eur J Pediatr (2004) 0.85
Recombinant human activated protein C improves endotoxemia-induced endothelial dysfunction: a blood-free model in isolated mouse arteries. Am J Physiol Heart Circ Physiol (2009) 0.85
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Thromb Haemost (2003) 0.85
Venous thromboembolism in cirrhosis: a review of the literature. Can J Gastroenterol (2012) 0.85
Tissue factor pathway inhibitor: a new link among arterial stiffness, pulse pressure, and coagulation in postmenopausal women. Arterioscler Thromb Vasc Biol (2011) 0.85
Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study. Thromb Res (2013) 0.85
Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization. Pediatr Infect Dis J (2013) 0.84
Phenotyping the haemostatic system by thrombography--potential for the estimation of thrombotic risk. Thromb Res (2004) 0.84
Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis. Arch Cardiovasc Dis (2011) 0.84
Predictors of pneumocystosis or tuberculosis in HIV-infected Asian patients with AFB smear-negative sputum pneumonia. J Acquir Immune Defic Syndr (2008) 0.83
Comparative evaluation of schistocyte counting by an automated method and by microscopic determination. Am J Clin Pathol (2004) 0.83
Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery. Eur J Clin Pharmacol (2012) 0.81
Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability. Pathophysiol Haemost Thromb (2003) 0.81
Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty. Pathophysiol Haemost Thromb (2006) 0.81
Allelic frequency of the factor V Leiden mutation and of the pro-thrombin gene 20210A mutation in healthy Tunisian population. Thromb Haemost (2004) 0.80
Molecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159). PLoS One (2011) 0.80
[Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report]. Ann Biol Clin (Paris) (2011) 0.80
How can we explain the gap between randomised studies and 'real life' practice in postoperative transfusion triggers? Do we need to change recommended thresholds for transfusion? Eur J Anaesthesiol (2012) 0.80
Factors associated with negative direct sputum examination in Asian and African HIV-infected patients with tuberculosis (ANRS 1260). PLoS One (2011) 0.79
Efficacy of delayed thromboprophylaxis with dabigatran: pooled analysis. Thromb Res (2012) 0.79
Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study. Thromb Haemost (2012) 0.79
Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal. MedGenMed (2007) 0.79
Pellets for oral administration of low-molecular-weight heparin. Drug Dev Ind Pharm (2009) 0.79
Mechanisms of antiphospholipid-induced thrombosis: effects on the protein C system. Curr Rheumatol Rep (2009) 0.79
Finding knizocytes in a peripheral blood smear. Am J Hematol (2011) 0.79
Thromboangiitis obliterans and endothelial function. Eur J Clin Invest (2010) 0.79
Transient red-blood-cell morphological anomalies after acute liver dysfunction. Eur J Haematol (2009) 0.78
Polyarteritis nodosa presenting as acute leg ischemia. J Rheumatol (2003) 0.78
Unexpected persistence of platelet hyporeactivity beyond the neonatal period: a flow cytometric study in neonates, infants and older children. Thromb Haemost (2003) 0.78
Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension. Thromb Res (2010) 0.78
PFA-100 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty? Thromb Res (2002) 0.78
[Central nervous system involvement in scleroderma]. Ann Med Interne (Paris) (2002) 0.78
Clinical trials and E-health: impact of new information technology applied to clinical trials (including source data-medical records) and to human and drug research. Therapie (2010) 0.77
Platelet activation induced by human antibodies to interleukin-8. Blood (2002) 0.77
Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia. Thromb Res (2009) 0.77
Dysmegakaryopoiesis, a clue for an early diagnosis of familial platelet disorder with propensity to acute myeloid leukemia in case of unexplained inherited thrombocytopenia associated with normal-sized platelets. J Pediatr Hematol Oncol (2011) 0.77
Cleaved protein S (PS), total PS, free PS, and activated protein C cofactor activity as risk factors for venous thromboembolism. Clin Chem (2003) 0.77